Press Releases




Return to Press Releases

Mahwah, NJ, April 18, 2001. DOBI Medical Systems, LLC, the high-tech medical device company that has developed a unique means of differentiating malignant from benign tumors in the breast by identifying angiogenesis, announced today that it has expanded its senior management team this year with the addition of three new Vice Presidents.
John D. Gardner has been named Vice President of Technology.  Mr. Gardner brings over 22 years of experience in electronics, software and system development to DOBI Medical Systems.  His most recent 14 years were in imaging device development including ultrasound systems for cardiology and radiology, video microscopes for studying microcirculation and angiogenesis, optical nonöinvasive hemoglobin measurement devices and x-ray and linear accelerators used in cancer therapy.

Dale A. Johnson has been named Group Vice President for Business Development.  Mr. Johnson brings over 19 years of experience in the medical and biotechnology industry and during the last five years he served as the president of a medical communications company.  Prior to that he was a senior executive in marketing at Glaxo, Inc. where he served as the international marketing manager for both pharmaceutical and medical products.

Julie G. Martin has been named Vice President, Marketing.  Ms. Martin has extensive senior executive clinical, marketing, and business development experience÷with the last 8 years in womenâs health.  Ms. Martin is currently on the Board of Directors of the San Diego Affiliate of the Susan G. Komen Breast Cancer Foundation, where she helps others from her own experiences as a breast cancer survivor.  She also speaks nationally on a variety of women's health issues.

In announcing the new members of the management team, Phillip C. Thomas, President and Chief Executive Officer of DOBI Medical Systems said, äWe are very enthusiastic about the addition of these three key executives.  Each is an outstanding professional with important and valuable background, experience and credentials to help DOBI Medical Systems continue to grow.  We expect them to make significant contributions in each of their areas of expertise that will enable us to move forward immediately with a number of valuable initiatives.

About DOBI Medical Systems
DOBI Medical Systems, headquartered in Mahwah, New Jersey, is a privately held biomedical device company with proprietary technology based upon detection of angiogenesis to determine the presence of cancer. The Company's first product, the Dynamic Optical Breast Imaging (DOBI) System, called ComfortScan, is initially intended to be an adjunct to mammography with the objective of providing a high degree of specificity in detecting benign lesions. Currently the product is designated an investigational device and may be used only for research purposes in the U.S. pending FDA approval.

Except for historical information contained herein, the matters discussed in this news release may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not guarantees of future performance due to factors that could cause actual results to differ materially including, but not limited to, results of future clinical trials, technical risks associated with new technology development, government regulatory approval, market acceptance of our product, competition and technological change.

Return to Press Releases

For further information:
Please contact: Phillip C. Thomas, Chief Executive Officer

DOBI Medical International
1200 MacArthur Blvd.
Mahwah, New Jersey 07430
Voice: (201) 760 6464
Fax: (201) 760 8860


calendario | newsletter | relacoes | atribuicoes | acidentesincidentes | legisot | reflegisd | apresentacao | missao | contactos
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 1 | 2 | 3 | 4 | 5